BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen SW, Chen YX, Zhang XR, Qian H, Chen WZ, Xie WF. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats. Gene Ther. 2008;15:1424-1435. [PMID: 18509379 DOI: 10.1038/gt.2008.93] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Taleb H, Maddocks SE, Morris RK, Kanekanian AD. Chemical characterisation and the anti-inflammatory, anti-angiogenic and antibacterial properties of date fruit (Phoenix dactylifera L.). Journal of Ethnopharmacology 2016;194:457-68. [DOI: 10.1016/j.jep.2016.10.032] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
2 Ge WS, Wu JX, Fan JG, Wang YJ, Chen YW. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World J Gastroenterol 2011; 17(36): 4090-4098 [PMID: 22039322 DOI: 10.3748/wjg.v17.i36.4090] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
3 Kassel KM, Sullivan BP, Luyendyk JP. Lipopolysaccharide enhances transforming growth factor β1-induced platelet-derived growth factor-B expression in bile duct epithelial cells. J Gastroenterol Hepatol 2012;27:714-21. [PMID: 22004089 DOI: 10.1111/j.1440-1746.2011.06941.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Ando K, Shih YH, Ebarasi L, Grosse A, Portman D, Chiba A, Mattonet K, Gerri C, Stainier DYR, Mochizuki N, Fukuhara S, Betsholtz C, Lawson ND. Conserved and context-dependent roles for pdgfrb signaling during zebrafish vascular mural cell development. Dev Biol 2021;479:11-22. [PMID: 34310924 DOI: 10.1016/j.ydbio.2021.06.010] [Reference Citation Analysis]
5 Ge WS, Wang YJ, Wu JX, Fan JG, Chen YW, Zhu L. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep. 2014;9:2145-2151. [PMID: 24691643 DOI: 10.3892/mmr.2014.2099] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
6 Zhong W, Shen WF, Ning BF, Hu PF, Lin Y, Yue HY, Yin C, Hou JL, Chen YX, Zhang JP. Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats. Hepatology. 2009;50:1524-1536. [PMID: 19787807 DOI: 10.1002/hep.23189] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
7 Kim KH, Park KK. Small RNA- and DNA-based gene therapy for the treatment of liver cirrhosis, where we are? World J Gastroenterol 2014; 20(40): 14696-14705 [PMID: 25356032 DOI: 10.3748/wjg.v20.i40.14696] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Wu K, Ye C, Lin L, Chu Y, Ji M, Dai W, Zeng X, Lin Y. Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT. Clin Sci (Lond) 2016;130:1469-80. [PMID: 27226339 DOI: 10.1042/CS20160334] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 4.2] [Reference Citation Analysis]
9 Wu X, Liu G, Mu M, Peng Y, Li X, Deng L, Zhang Z, Chen M, You S, Kong X. Augmenter of Liver Regeneration Gene Therapy Using a Novel Minicircle DNA Vector Alleviates Liver Fibrosis in Rats. Human Gene Therapy 2016;27:880-91. [DOI: 10.1089/hum.2016.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yang N, Mahato RI. GFAP promoter-driven RNA interference on TGF-β1 to treat liver fibrosis. Pharm Res. 2011;28:752-761. [PMID: 21347569 DOI: 10.1007/s11095-011-0384-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
11 Wiedon A, Tölle M, Bastine J, Schuchardt M, Huang T, Jankowski V, Jankowski J, Zidek W, van der Giet M. Uridine adenosine tetraphosphate (Up4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y2 receptor and cross-communication to the PDGF receptor. Biochem Biophys Res Commun 2012;417:1035-40. [PMID: 22214933 DOI: 10.1016/j.bbrc.2011.12.088] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
12 Li Y, Liu Z, Lu W, Zhao M, Xiao H, Hu T, Ma J, Zheng Z, Jia J, Wu H. A label-free electrochemical aptasensor based on the core-shell Cu-MOF@TpBD hybrid nanoarchitecture for the sensitive detection of PDGF-BB. Analyst 2021;146:979-88. [PMID: 33554228 DOI: 10.1039/d0an01885f] [Reference Citation Analysis]
13 Borkham-Kamphorst E, Weiskirchen R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev. 2016;28:53-61. [PMID: 26547628 DOI: 10.1016/j.cytogfr.2015.10.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 10.1] [Reference Citation Analysis]
14 Al-Rasheed NM, Attia HA, Mohamad RA, Al-Rasheed NM, Al-Amin MA, Al-Onazi A. Aqueous Date Flesh or Pits Extract Attenuates Liver Fibrosis via Suppression of Hepatic Stellate Cell Activation and Reduction of Inflammatory Cytokines, Transforming Growth Factor- β 1 and Angiogenic Markers in Carbon Tetrachloride-Intoxicated Rats. Evid Based Complement Alternat Med 2015;2015:247357. [PMID: 25945106 DOI: 10.1155/2015/247357] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
15 Hu PF, Xie WF. Targeted RNA interference for hepatic fibrosis. Expert Opin Biol Ther. 2009;9:1305-1312. [PMID: 19723017 DOI: 10.1517/14712590903213677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Kim J, Jung Y. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells. Vitam Horm. 2016;102:121-149. [PMID: 27450733 DOI: 10.1016/bs.vh.2016.04.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kurahashi M, Nakano Y, Peri LE, Townsend JB, Ward SM, Sanders KM. A novel population of subepithelial platelet-derived growth factor receptor α-positive cells in the mouse and human colon. Am J Physiol Gastrointest Liver Physiol. 2013;304:G823-G834. [PMID: 23429582 DOI: 10.1152/ajpgi.00001.2013] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
18 Huang Y, Feng H, Kan T, Huang B, Zhang M, Li Y, Shi C, Wu M, Luo Y, Yang J, Xu F. Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells. PLoS One 2013;8:e73492. [PMID: 24023685 DOI: 10.1371/journal.pone.0073492] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
19 Quillin RC, Wilson GC, Nojima H, Freeman CM, Wang J, Schuster RM, Blanchard JA, Edwards MJ, Gandhi CR, Gulbins E. Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice. Hepatol Res. 2014; May 4. [Epub ahead of print]. [PMID: 24796378 DOI: 10.1111/hepr.12352] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
20 Kikuchi A, Singh S, Poddar M, Nakao T, Schmidt HM, Gayden JD, Sato T, Arteel GE, Monga SP. Hepatic Stellate Cell-Specific Platelet-Derived Growth Factor Receptor-α Loss Reduces Fibrosis and Promotes Repair after Hepatocellular Injury. Am J Pathol 2020;190:2080-94. [PMID: 32615075 DOI: 10.1016/j.ajpath.2020.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Wang X, Wu X, Zhang A, Wang S, Hu C, Chen W, Shen Y, Tan R, Sun Y, Xu Q. Targeting the PDGF-B/PDGFR-β Interface with Destruxin A5 to Selectively Block PDGF-BB/PDGFR-ββ Signaling and Attenuate Liver Fibrosis. EBioMedicine 2016;7:146-56. [PMID: 27322468 DOI: 10.1016/j.ebiom.2016.03.042] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
22 Takahashi Y, Nishikawa M, Takakura Y. Nonviral vector-mediated RNA interference: Its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Advanced Drug Delivery Reviews 2009;61:760-6. [DOI: 10.1016/j.addr.2009.04.006] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 6.0] [Reference Citation Analysis]
23 Foglia B, Cannito S, Bocca C, Parola M, Novo E. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis. Int J Mol Sci. 2019;20. [PMID: 31159366 DOI: 10.3390/ijms20112700] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
24 Maepa MB, Ely A, Arbuthnot P. How successful has targeted RNA interference for hepatic fibrosis been? Expert Opin Biol Ther 2018;18:381-8. [PMID: 29265946 DOI: 10.1080/14712598.2018.1420775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
25 Quadri S, Siragy HM. Regulation of (pro)renin receptor expression in mIMCD via the GSK-3β-NFAT5-SIRT-1 signaling pathway. Am J Physiol Renal Physiol. 2014;307:F593-F600. [PMID: 24990896 DOI: 10.1152/ajprenal.00245.2014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
26 He L, Zhang S, Ji H, Wang M, Peng D, Yan F, Fang S, Zhang H, Jia C, Zhang Z. Protein-templated cobaltous phosphate nanocomposites for the highly sensitive and selective detection of platelet-derived growth factor-BB. Biosens Bioelectron 2016;79:553-60. [PMID: 26749096 DOI: 10.1016/j.bios.2015.12.095] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
27 Ge WS, Wang YJ, Wu JX, Fan JG, Chen YW, Zhu L. β-catenin is overexpressed in hepatic fibrosis and blockage of Wnt/β-catenin signaling inhibits hepatic stellate cell activation. Mol Med Rep. 2014;9:2145-2151. [PMID: 24691643 DOI: 10.3892/mmr.] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Hasanzadeh M, Razmi N, Mokhtarzadeh A, Shadjou N, Mahboob S. Aptamer based assay of plated-derived grow factor in unprocessed human plasma sample and MCF-7 breast cancer cell lysates using gold nanoparticle supported α-cyclodextrin. Int J Biol Macromol 2018;108:69-80. [PMID: 29180051 DOI: 10.1016/j.ijbiomac.2017.11.149] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 8.4] [Reference Citation Analysis]
29 Vannucchi MG, Traini C, Manetti M, Ibba-Manneschi L, Faussone-Pellegrini MS. Telocytes express PDGFRα in the human gastrointestinal tract. J Cell Mol Med 2013;17:1099-108. [PMID: 24151977 DOI: 10.1111/jcmm.12134] [Cited by in Crossref: 114] [Cited by in F6Publishing: 114] [Article Influence: 14.3] [Reference Citation Analysis]
30 Brenner M, Messing A. Regulation of GFAP Expression. ASN Neuro 2021;13:1759091420981206. [PMID: 33601918 DOI: 10.1177/1759091420981206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 van Dijk F, Olinga P, Poelstra K, Beljaars L. Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma. Front Med (Lausanne). 2015;2:72. [PMID: 26501061 DOI: 10.3389/fmed.2015.00072] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
32 Cannito S, Novo E, Parola M. Therapeutic pro-fibrogenic signaling pathways in fibroblasts. Adv Drug Deliv Rev 2017;121:57-84. [PMID: 28578015 DOI: 10.1016/j.addr.2017.05.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
33 Hao ZM, Fan XB, Li S, Lv YF, Su HQ, Jiang HP, Li HH. Vaccination with platelet-derived growth factor B kinoids inhibits CCl4-induced hepatic fibrosis in mice. J Pharmacol Exp Ther. 2012;342:835-842. [PMID: 22711911 DOI: 10.1124/jpet.112.194357] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
34 Díaz-Rivera A, Meza-Ríos A, Chagoya de Sánchez V, Velasco-Loyden G, García-Benavides L, Jave-Suarez LF, Monroy-Ramirez HC, Santos-García A, Armendáriz-Borunda J, Sandoval-Rodríguez A. Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats. PLoS One 2020;15:e0228729. [PMID: 32053633 DOI: 10.1371/journal.pone.0228729] [Reference Citation Analysis]
35 Chen Y, Zheng S, Qi D, Zheng S, Guo J, Zhang S, Weng Z. Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One. 2012;7:e46512. [PMID: 23056328 DOI: 10.1371/journal.pone.0046512] [Cited by in Crossref: 78] [Cited by in F6Publishing: 93] [Article Influence: 7.8] [Reference Citation Analysis]
36 Ding H, Wen Z. Overexpression of C‑sis inhibits H2O2‑induced Buffalo rat liver cell apoptosis in vitro and alleviates liver injury in a rat model of fulminant hepatic failure. Int J Mol Med 2018;42:873-82. [PMID: 29786113 DOI: 10.3892/ijmm.2018.3684] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
37 Kim J, Jung Y. Potential role of thymosin Beta 4 in liver fibrosis. Int J Mol Sci 2015;16:10624-35. [PMID: 26006229 DOI: 10.3390/ijms160510624] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
38 Mercedes R, Brown J, Minard C, Tsai CM, Devaraj S, Munden M, Leung D. A Liver Biopsy Validation Pilot Study of Shear Wave Elastography, APRI, FIB-4, and Novel Serum Biomarkers for Liver Fibrosis Staging in Children With Chronic Viral Hepatitis. Glob Pediatr Health 2020;7:2333794X20938931. [PMID: 32821773 DOI: 10.1177/2333794X20938931] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Kuo WL, Yu MC, Lee JF, Tsai CN, Chen TC, Chen MF. Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice. J Gastrointest Surg 2012;16:361-9. [PMID: 22068968 DOI: 10.1007/s11605-011-1764-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
40 Jiang Y, Zhao Y, He F, Wang H. Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice. Hum Gene Ther 2019;30:179-96. [PMID: 30024280 DOI: 10.1089/hum.2018.047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
41 Li Q, Yan Z, Li F, Lu W, Wang J, Guo C. The improving effects on hepatic fibrosis of interferon-γ liposomes targeted to hepatic stellate cells. Nanotechnology. 2012;23:265101. [PMID: 22700686 DOI: 10.1088/0957-4484/23/26/265101] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]